The safety of nanomedicines is a primary concern in toxicology. While they offer improved drug delivery, the nano-sized particles can pose novel risks, including unexpected interactions with biological systems. Their small size may enable them to cross biological barriers, such as the blood-brain barrier, leading to unforeseen toxicological effects. Thus, comprehensive safety assessments are essential to evaluate their interaction with the human body.
